Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

590 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients: The BRIGHTEN study.
Narita I, Hayashi T, Maruyama S, Masaki T, Nangaku M, Nishino T, Sato H, Sofue T, Wada T, Imai E, Iwasaki M, Mizuno K, Hase H, Kamouchi M, Yamamoto H, Kagimura T, Tanabe K, Kato H, Wada T, Usui T, Akizawa T, Hirakata H, Tsubakihara Y. Narita I, et al. Among authors: akizawa t. PLoS One. 2022 Nov 29;17(11):e0277921. doi: 10.1371/journal.pone.0277921. eCollection 2022. PLoS One. 2022. PMID: 36445882 Free PMC article.
Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favorable control of the serum phosphorus and calcium levels in Japanese dialysis patients.
Fukagawa M, Yumita S, Akizawa T, Uchida E, Tsukamoto Y, Iwasaki M, Koshikawa S; KRN1493 study group. Fukagawa M, et al. Among authors: akizawa t. Nephrol Dial Transplant. 2008 Jan;23(1):328-35. doi: 10.1093/ndt/gfm534. Epub 2007 Aug 23. Nephrol Dial Transplant. 2008. PMID: 17717030 Clinical Trial.
Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.
Yokoyama H, Kawaguchi T, Wada T, Takahashi Y, Higashi T, Yamazaki S, Fukuhara S, Akiba T, Akizawa T, Asano Y, Kurokawa K, Saito A; J-DOPPS Research Group. Yokoyama H, et al. Among authors: akizawa t. Nephron Clin Pract. 2008;109(2):c100-8. doi: 10.1159/000142528. Epub 2008 Jul 3. Nephron Clin Pract. 2008. PMID: 18596379
Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods.
Imai E, Matsuo S, Makino H, Watanabe T, Akizawa T, Nitta K, Iimuro S, Ohashi Y, Hishida A; CKD-JAC Study Group. Imai E, et al. Among authors: akizawa t. Hypertens Res. 2008 Jun;31(6):1101-7. doi: 10.1291/hypres.31.1101. Hypertens Res. 2008. PMID: 18716357
Revised equations for estimated GFR from serum creatinine in Japan.
Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A; Collaborators developing the Japanese equation for estimated GFR. Matsuo S, et al. Am J Kidney Dis. 2009 Jun;53(6):982-92. doi: 10.1053/j.ajkd.2008.12.034. Epub 2009 Apr 1. Am J Kidney Dis. 2009. PMID: 19339088
590 results